How much funding can be received?

There is no informations about how much funding can be received.

What is the deadline to apply?

The deadline to apply is not specified.

Who are the financial supporters of the Accelerate Program for Quebec Emerging Companies?

Accelerate Program for Quebec Emerging Companies is funded by adMare Bioinnovations

What are Accelerate Program for Quebec Emerging Companies's eligibility criterias?

The applicant must be an emerging company based in Quebec. The company must demonstrate innovation in their field. The application should include a detailed business plan.

Accelerate Program for Quebec Emerging Companies

grant_single|update January 24, 2025

QC, Canada

Support for Therapeutics, Med-Tech and Digital Health innovators

grant_single_labels|summary

grant_single_labels|preview

grant_single_labels|projects

grant_single_labels|admissibility

grant_single_labels|criteria

grant_single_labels|apply

grant_single_labels|otherInfo

grant_single_labels|documents

grant_single_labels|contact

grant_single_labels|summary

grant_single|eligibleFinancing

grant_single|noCondition

grant_single|deadlines

grant_single|openingDate August 20, 2021

grant_single|financingType

Expert Advice

grant_single|eligibleIndustries

Manufacturing
Professional, scientific and technical services
Health care and social assistance

grant_single|grantors

adMare Bioinnovations

grant_single|status

grant_card_status|open

grant_single_labels|preview

Get customized support and discounted rate on rental fees for lab and office spaces to help you advance to significant seed or Series A financing, if you’re an early-stage life sciences business.

grant_single_labels|projects

grant_single|admissibleProjectsExample

$ 800,000

Development of a novel gene therapy for rare genetic disorders

$ 750,000

Developing early-stage diagnostics technology for infectious diseases

$ 600,000

Collaborative research with University of Ottawa on cancer biomarker discovery

$ 1,200,000

Translation of academic research to therapeutic products for Alzheimer's disease

$ 1,000,000

Initial development of a biodegradable nano-coating for medical implants

$ 1,100,000

Collaborative effort with Canadian researchers on revolutionary diabetes treatment

grant_single_labels|admissibility

Eligibility for this grant is determined by specific requirements related to the applicant's profile and proposed activities.

The company must be part of the Canadian life sciences sector, focusing on biopharmaceuticals, medical devices, or digital health solutions.
The technology proposed must demonstrate differentiation and a competitive advantage.
The market opportunity for the technology must be significant.
The company must have a high-quality team in place.
The scope and strength of IP coverage must be clear and defendable.
The proposed project must offer a potential return on investment.
The seed investment must be capable of bringing the company to a value inflection point attractive to private capital.

grant_eligibility_criteria|who_can_apply

Academic researchers and emerging Canadian life sciences companies focused on biopharmaceuticals, medical devices, and digital health solutions can apply for this grant. AdMare seeks projects involving novel and transformative pre-clinical technologies with commercial potential that address unmet medical needs.

grant_eligibility_criteria|eligible_expenses

adMare provides opportunities for collaborations that transform academic research into new therapeutic products and bio-innovation companies. The eligible projects focus on early-stage technology development and company-building in the life sciences sector.

Collaboration with researchers to translate leading academic research into therapeutics and health innovations.
Identification and advancement of pre-clinical technologies addressing unmet medical needs.
Creation of new Canadian life sciences companies by partnering with scientists and entrepreneurs.
Development of a business case to attract private sector investment.
Support for growth of existing life sciences companies through shared expertise and investment capital.

grant_single_labels|criteria

The evaluation and selection criteria for projects under this grant focus on ensuring alignment with adMare's strategic investment goals.

Differentiation and competitive advantage of the technology.
Market opportunity and potential for growth.
Quality and experience of the team involved.
Scope and strength of intellectual property coverage.
Potential return on investment.
The impact of an adMare seed investment in building the company to a value inflection point that attracts private capital.

grant_single_labels|apply

Step 1: Identify opportunities
Implications: Assess potential therapeutic opportunities discovered by Canadian researchers that have commercial potential.
Step 2: Develop & advance technologies
Implications: Collaborate with founding researchers to progress the discovery towards the next development milestone and investment readiness. Dedicate professional R&D resources and infrastructure to generate valuable data and IP.
Step 3: Build partnerships
Implications: Engage partners from academia, industry, patient foundations, the investment community, and key opinion leaders to support the advancement of technologies and creation of new companies.
Step 4: Assemble a team
Implications: Work with co-founders to build an experienced management and scientific team to create a compelling business case for investors.
Step 5: Secure seed investment
Implications: Evaluate the differentiation, market opportunity, team quality, IP coverage, and potential ROI to secure adMare seed investment that will make the company attractive to private capital.